This inventor holds 7 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Beckman Research Institute, City of Hope, The University of Texas System, Yinnuolai Biotech Ltd.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Upland, CA (US) (2023)
- Duarte, CA (US) (2021 - 2024)
Company Filing History:
7 out of 692 
5 out of 5,645 
1 out of 1 Years Active: 2021-2026
Title: Innovations and Contributions of Inventor Hong Qin
Introduction
Hong Qin is a notable inventor based in Duarte, California, with a significant portfolio of six patents. His work primarily focuses on advancements in immunotherapy, particularly in the development of targeted therapies for cancer and autoimmune diseases.
Latest Patents
Among his latest patents is the invention titled "BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof." This patent describes T cells that express a chimeric antigen receptor (CAR) specifically targeted to the B cell activating factor receptor (BAFF-R). The BAFF-R CAR includes a domain that binds to BAFF-R, providing methods for making and utilizing this innovative therapy. Another significant patent is "BAFF-R antibodies and uses thereof," which details BAFF-R antibodies along with compositions and methods for their production and application. These antibodies are particularly useful in treating cancer and autoimmune diseases.
Career Highlights
Throughout his career, Hong Qin has made substantial contributions to the field of immunotherapy. His work has been instrumental in advancing the understanding and treatment of various diseases through innovative approaches.
Collaborations
Hong Qin has collaborated with esteemed colleagues, including Larry W. Kwak and Jingxing Li, enhancing the impact of his research and inventions.
Conclusion
In summary, Hong Qin's contributions to the field of immunotherapy through his patents and collaborations highlight his role as a significant innovator in medical science. His work continues to pave the way for new treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile